B of A Securities Downgrades GoodRx Holdings to Underperform, Lowers Price Target to $4.5
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Michael Cherny downgraded GoodRx Holdings (NASDAQ:GDRX) from Buy to Underperform and reduced the price target from $8 to $4.5.
January 02, 2024 | 1:20 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
GoodRx Holdings was downgraded by B of A Securities from Buy to Underperform, with a significant price target cut from $8 to $4.5.
The downgrade by a major analyst from Buy to Underperform, accompanied by a nearly 50% reduction in price target, is likely to negatively impact investor sentiment and could lead to a short-term decline in GoodRx Holdings' stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100